64x Bio

64x Bio is a biotechnology company focused on revolutionizing the cell and gene therapy industry through innovative cell line engineering. They develop novel high-throughput genome engineering and screening technologies, combined with computational tools, to generate optimized mammalian cell lines for the design and manufacture of next-generation therapeutics. Their platform enables pharmaceutical and biotechnology companies, as well as CDMOs, to bring cell and gene therapies to patients more effectively.

64x Bio was founded by a team of experts in the field, including George Church, a renowned geneticist at Harvard. The company has raised significant funding and has been featured in various publications for its cutting-edge technology. They are based in Brisbane, California, and are actively seeking talented individuals to join their growing team.

64x Bio is a company dedicated to revolutionizing the cell and gene therapy landscape. Their mission is to create highly optimized and previously unattainable mammalian cell lines through the use of innovative high-throughput genome engineering and screening technologies. These technologies, which are paired with computational tools in a design loop, are aimed at enhancing the design and manufacture of next-generation therapeutics. 64x Bio's platform is designed to help pharmaceutical and biotechnology companies, as well as CDMOs, bring cell and gene therapies to patients more effectively.

64x Bio fosters a collaborative and cross-disciplinary culture focused on innovation and the development of technologies that benefit patients. The company values teamwork and a shared mission to bring cell and gene therapies to market. Their emphasis on scientific advancement and a commitment to improving human health drives a dynamic and ambitious work environment.